The molecular interaction of human anti-apoptotic proteins and in silico ADMET, drug-likeness and toxicity computation of N-cyclohexylmethacrylamide

被引:5
|
作者
Cankaya, Nevin [1 ]
Azarkan, Serap Yalcin [2 ]
Tanis, Emine [3 ]
机构
[1] Usak Univ, Dept Chem, Usak, Turkey
[2] Kirsehir Ahi Evran Univ, Dept Mol Biol & Genet, Kirsehir, Turkey
[3] Kirsehir Ahi Evran Univ, Dept Elect Elect Engn, Kirsehir, Turkey
关键词
Molecular docking; anti-apoptotic proteins; ADMET; drug-likeness; toxicology; DISCOVERY;
D O I
10.1080/01480545.2021.1894711
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cancer is an uncontrolled growth of normal cells and apoptosis has an important role in cancer progression and cancer treatment. Antiapoptotic proteins are overexpressed in several tumors including breast, brain, lung cancer cells. The protein-ligand interaction has a critical role in drug designing. The present study aims to evaluate the interaction of synthesized N-cyclohexylmethacrylamide (NCMA) with proteins using in silico molecular docking and toxicity analyses. The NCMA monomer was synthesized and characterized by our team, previously. Kinetics stability, binding affinities and toxic potential of protein-NCMA complex were examined with the aid of molecular simulation. The toxicity results of this study indicate that NCMA is a sample with low toxic potential. According to the docking results, NCMA may be a drug active substance with chemical modifications and toxicity results support this situation. The drug-likeness and ADMET parameters were screened properties of NCMA.
引用
收藏
页码:1963 / 1970
页数:8
相关论文
共 36 条
  • [21] Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins
    Roy, G
    Horton, JK
    Roy, R
    Denning, T
    Mitra, S
    Boldogh, I
    ONCOGENE, 2000, 19 (01) : 141 - 150
  • [22] Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins
    Gargi Roy
    Julie K Horton
    Rabindra Roy
    Timothy Denning
    Sankar Mitra
    Istvan Boldogh
    Oncogene, 2000, 19 : 141 - 150
  • [23] The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl
    Xu, HB
    Tai, J
    Ye, H
    Kang, CB
    Yoon, HS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (04) : 938 - 944
  • [24] Molecular docking studies, drug-likeness and in-silico ADMET prediction of some novel β-Amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives as elevators of p53 protein levels
    Ibrahim, Zakari Ya'u
    Uzairu, Adamu
    Shallangwa, Gideon
    Abechi, Stephen
    SCIENTIFIC AFRICAN, 2020, 10
  • [25] Synthesis, molecular docking, drug likeness, in silico toxicity and DFT studies of small molecules as p53-MDM2 interaction and COX-2 dual inhibitors
    Basha, N. Jeelan
    Akshay, KT.
    Mohan, RM.
    Javeed, Mohammad
    Sharma, Omkar Mukesh
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1322
  • [26] Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells
    Hilovska, Lucia
    Jendzelovsky, Rastislav
    Jendzelovska, Zuzana
    Koval, Jan
    Fedorocko, Peter
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (04) : 1572 - 1584
  • [27] Molecular alterations in anti-apoptotic BCL2 family proteins in breast cancer cell line models, drug sensitivities and dependencies to guide the development of BCL2 inhibitors
    Voutsadakis, Ioannis A.
    GENE, 2022, 847
  • [28] Crystal structure, DFT calculation, molecular docking, in vitro biological activity evaluation and in silico drug-likeness prediction of N-((1H-indol-3-yl)methyl)-4-(piperidin-1-yl)aniline
    Liu, Tao
    Luan, Liang
    Zhang, Zhen
    Li, Ziyue
    Wu, Chengjun
    Sun, Tiemin
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1312
  • [29] Novel N-benzyl-2-oxo-1,2-dihydrofuro [3,4-d]pyrimidine-3 (4H)-carboxamide as anticancer agent: Synthesis, drug-likeness, ADMET profile, DFT and molecular modelling against EGFR target
    Yilmaz, Aysen Suekinci
    Ulucam, Guhergul
    HELIYON, 2023, 9 (01)
  • [30] 3D-QSAR, drug-likeness, ADMET prediction, and molecular docking studies in silico of novel 5-oxo-1-thioxo-4,5-dihydro-1H-thiazolo[3,4-a]quinazoline derivatives as MALT1 protease inhibitors for the treatment of B cell lymphoma
    Rachid Haloui
    Ossama Daoui
    Khaoula Mkhayar
    Mohamed El Yaqoubi
    Souad Elkhattabi
    Amal Haoudi
    Youssef Kandri Rodi
    Fouad Chahdi Ouazzani
    Samir Chtita
    Chemical Papers, 2023, 77 : 2255 - 2274